Senate Democrats Probe UnitedHealth Over Nursing Home Care Cuts

The investigation centers on a reported bonus scheme within Optum, a UnitedHealth subsidiary, which allegedly rewards nursing homes for reducing hospital admissions. According to evidence gathered by The Guardian, these financial incentives—likened by critics to stockbroker tactics—have resulted in delayed medical interventions. In one documented instance, a resident suffered permanent brain damage following a denied transfer request.

Wyden and Warren’s letter to the CEO highlights a pattern of behavior, pointing to prior allegations of the company using artificial intelligence to deny care to Medicare Advantage enrollees. While UnitedHealth maintains that its programs represent industry best practices, the senators argue that these methods create dangerous conflicts of interest. Whistleblowers, including former medical staff, contend the company forces professionals to trade ethical obligations for cost-cutting goals. With over $34 billion in annual profits, UnitedHealth now faces mounting scrutiny from federal regulators, lawmakers, and disillusioned investors, signaling a growing institutional challenge to the company's expansive influence over the U.S. medical system.